JP2020536503A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020536503A5 JP2020536503A5 JP2020514246A JP2020514246A JP2020536503A5 JP 2020536503 A5 JP2020536503 A5 JP 2020536503A5 JP 2020514246 A JP2020514246 A JP 2020514246A JP 2020514246 A JP2020514246 A JP 2020514246A JP 2020536503 A5 JP2020536503 A5 JP 2020536503A5
- Authority
- JP
- Japan
- Prior art keywords
- lnc
- mir
- lncrnas
- listed
- tenm3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762554427P | 2017-09-05 | 2017-09-05 | |
| US62/554,427 | 2017-09-05 | ||
| PCT/EP2018/073905 WO2019048500A1 (en) | 2017-09-05 | 2018-09-05 | NON-CODING RNA (RNANC) FOR THE DIAGNOSIS OF COGNITIVE DISORDERS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020536503A JP2020536503A (ja) | 2020-12-17 |
| JP2020536503A5 true JP2020536503A5 (https=) | 2021-10-21 |
| JP7398806B2 JP7398806B2 (ja) | 2023-12-15 |
Family
ID=63517886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020514246A Active JP7398806B2 (ja) | 2017-09-05 | 2018-09-05 | 認知障害の診断用のノンコーディングＲＮＡ（ｎｃＲＮＡ） |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11718879B2 (https=) |
| EP (1) | EP3679157B1 (https=) |
| JP (1) | JP7398806B2 (https=) |
| CN (1) | CN111373052A (https=) |
| WO (1) | WO2019048500A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4498086A3 (en) * | 2018-02-13 | 2025-04-02 | Toray Industries, Inc. | Kit or device and method for detecting dementia |
| WO2021201092A1 (ja) | 2020-03-31 | 2021-10-07 | 東レ株式会社 | 海馬萎縮を検出するためのキット又はデバイス及び方法 |
| KR102555878B1 (ko) * | 2020-04-23 | 2023-07-17 | 주식회사 바이오오케스트라 | 하향조절된 mirna의 진단 및 치료를 위한 용도 |
| KR102691806B1 (ko) * | 2020-04-23 | 2024-08-06 | 주식회사 바이오오케스트라 | 상향조절된 mirna의 진단 및 치료를 위한 용도 |
| CN113667737A (zh) * | 2020-07-31 | 2021-11-19 | 上海市精神卫生中心（上海市心理咨询培训中心） | Mci诊断标志物、mci诊断试剂盒及相应的检测方法 |
| CN112779331B (zh) * | 2021-02-05 | 2022-04-01 | 浙江萧山医院 | 一种血管痴呆血清外泌体microRNAs标志物及其应用 |
| CN113234812B (zh) * | 2021-06-09 | 2023-11-03 | 科德角国际生物医学科技(北京)有限公司 | 一种用于诊断阿尔茨海默病的诊断试剂 |
| CN113373230B (zh) * | 2021-06-18 | 2022-07-29 | 福建医科大学附属第一医院 | 检测生物标志物的试剂在诊断胃癌中的应用 |
| JP2023004314A (ja) * | 2021-06-25 | 2023-01-17 | 株式会社堀場製作所 | 心理的ストレスの検出方法及び検出用キット |
| JP7840033B2 (ja) * | 2021-11-02 | 2026-04-03 | 学校法人日本医科大学 | オキサリプラチン誘発性末梢神経障害バイオマーカー |
| WO2025011736A1 (en) | 2023-07-07 | 2025-01-16 | Genxpro Gmbh | A METHOD FOR AN IN VITRO DIAGNOSIS, PROGNOSIS, STAGING AND/OR TREATMENT MONITORING OF A NEURODEGENERATIVE DISEASE, NEUROLOGICAL DISEASE OR AMYLOID β-RELATED DISEASE |
| CN119020481B (zh) * | 2024-08-29 | 2026-01-30 | 河络新图生物科技(上海)有限公司 | 检测xcl2基因表达的物质在制备检测帕金森病产品中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6407132B1 (en) | 1997-07-25 | 2002-06-18 | James Black Foundation Limited | Substituted imidazole derivatives and their use as histamine H3 receptor ligands |
| AU2005206389A1 (en) | 2004-01-27 | 2005-08-04 | Compugen Ltd. | Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby |
| FR2882056B1 (fr) | 2005-02-15 | 2007-06-01 | Centre Nat Rech Scient | Dipyrromethenes-bore borocarbones insatures |
| WO2013024469A1 (en) | 2011-08-16 | 2013-02-21 | Rosetta Genomics Ltd. | Methods and compositions for diagnosis of alzheimer's desease |
| US9377472B2 (en) | 2012-04-30 | 2016-06-28 | Amoneta Diagnostics | Biological complex specific for Alzheimer's disease detection in vitro and use thereof |
| EP2733219B1 (en) * | 2012-11-16 | 2017-09-20 | Siemens Aktiengesellschaft | Diagnostic miRNA markers for Alzheimer |
| US20140272993A1 (en) * | 2013-03-15 | 2014-09-18 | The Translational Genomics Research Institute | Method of sequencing a full microrna profile from cerebrospinal fluid |
| WO2015031958A1 (en) * | 2013-09-06 | 2015-03-12 | Garvan Institute Of Medical Research | Regulatory molecules |
| WO2015179909A1 (en) * | 2014-05-26 | 2015-12-03 | The University Of Melbourne | Mirna biomarkers of alzheimer's disease |
| CN105950705B (zh) * | 2015-04-08 | 2019-10-22 | 中国人民解放军第二军医大学 | 一组microRNAs在制备阿尔兹海默氏症诊断试剂或诊断试剂盒中的应用 |
| EP3184646B1 (de) * | 2015-12-22 | 2019-04-17 | Siemens Aktiengesellschaft | Spezifische signaturen in alzheimer durch multizentrische mirna-profile |
| WO2020049135A1 (en) | 2018-09-05 | 2020-03-12 | Amoneta Diagnostics Sas | Long non-coding rnas (lncrnas) for the diagnosis and therapeutics of brain disorders, in particular cognitive disorders |
-
2018
- 2018-09-05 EP EP18765623.6A patent/EP3679157B1/en active Active
- 2018-09-05 CN CN201880068913.3A patent/CN111373052A/zh active Pending
- 2018-09-05 JP JP2020514246A patent/JP7398806B2/ja active Active
- 2018-09-05 US US16/644,812 patent/US11718879B2/en active Active
- 2018-09-05 WO PCT/EP2018/073905 patent/WO2019048500A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020536503A5 (https=) | ||
| JP2022501016A5 (https=) | ||
| Staats et al. | Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis | |
| Galimberti et al. | Circulating miRNAs as potential biomarkers in Alzheimer's disease | |
| US12018334B2 (en) | Controls for nucleic acid assays | |
| Goldberg et al. | Circulating microRNAs: a potential biomarker for cardiac damage, inflammatory response, and left ventricular function recovery in pediatric viral myocarditis | |
| JP7398806B2 (ja) | 認知障害の診断用のノンコーディングＲＮＡ（ｎｃＲＮＡ） | |
| ES2993025T3 (en) | Methods of using mirnas from bodily fluids for detection and differentiation of neurodegenerative diseases | |
| US10370717B2 (en) | Methods for the measurement of post-traumatic stress disorder microRNA markers | |
| WO2014192907A1 (ja) | 運動神経の障害を呈する疾患の鑑別に用いるマイクロｒｎａの検出方法 | |
| Kawada et al. | Analysis of gene-expression profiles by oligonucleotide microarray in children with influenza | |
| CN103103256B (zh) | 可用于检测与精神分裂症相关的drd4基因启动子区甲基化程度的试剂盒及其应用 | |
| Zanello et al. | Inflammatory gene expression signatures in idiopathic intracranial hypertension: possible implications in microgravity-induced ICP elevation | |
| Wardzyńska et al. | Circulating miRNA expression in asthmatics is age-related and associated with clinical asthma parameters, respiratory function and systemic inflammation | |
| Ali et al. | The Ifng antisense RNA 1 (IFNG-AS1) and growth arrest-specific transcript 5 (GAS5) are novel diagnostic and prognostic markers involved in childhood ITP | |
| JPWO2014168154A1 (ja) | 眼疾患を評価するためのマイクロアレイ及び眼疾患の評価方法 | |
| EP3899043A2 (en) | Mirnas as biomarkers for parkinson's syndrome | |
| CN110791562A (zh) | 用于检测2型糖尿病的miR-145-5P分子标记物及其扩增引物和应用 | |
| Zirnheld et al. | Distinguishing mild cognitive impairment from Alzheimer’s disease by increased expression of key circulating microRNAs | |
| KR102184840B1 (ko) | 외상 후 스트레스 장애 진단 또는 예측용 바이오마커 및 그의 용도 | |
| CN113151450A (zh) | 一种用于散发性肌萎缩性侧索硬化症和帕金森病早期诊断的生物标志物及其应用 | |
| US20080194711A1 (en) | Cx3Cr1 As A Marker Which Correlates With Both Disease And Disease Activity In Multiple Sclerosis Patients | |
| CN113373214B (zh) | Cd30在诊断脑神经相关疾病中的用途 | |
| Duncan | Investigating the Effects of TREM2 Modulation with In-Vitro Models & Profiling the Proteome of Alzheimer’s Disease (and other Neurological Diseases) Cerebrospinal Fluid | |
| US20200308647A1 (en) | Mirnas as biomarkers for alzheimer's disease |